Significance of MMP11 and P14ARF expressions in clinical outcomes of patients with laryngeal cancer
Background: To evaluate the association of MMP11 and P14 ARF expression in laryngeal squamous cell carcinoma (LSCC) with clinical pathological characteristics and survival. Methods: The mRNA and protein levels for both genes were determined in 65 LSCC patients. A log-rank test and Cox models were us...
Saved in:
Published in: | International journal of clinical and experimental medicine Vol. 8; no. 9; pp. 15581 - 15590 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
e-Century Publishing Corporation
15-09-2015
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: To evaluate the association of MMP11 and P14
ARF
expression in laryngeal squamous cell carcinoma (LSCC) with clinical pathological characteristics and survival. Methods: The mRNA and protein levels for both genes were determined in 65 LSCC patients. A log-rank test and Cox models were used to compare survival among different groups. Results: The mRNA expressions of MMP11 and P14
ARF
were significantly different between LSCC and their corresponding adjacent tissues (All P < 0.001). The expressions of MMP11 and P14
ARF
were correlated with several clinical characteristics (All P < 0.05). Patients with low MMP11 and high P14
ARF
expression had significantly better survival compared with those with high MMP11 and low P14
ARF
expression, respectively (All P < 0.05). The patients with surgery only had significantly better survival than those with chemoradiotherapy (log rank: P = 0.016), particularly in patients with low MMP11 and high P14
ARF
expression (log rank: P = 0.006). Furthermore, multivariable analysis showed that patients with low MMP11 and high P14
ARF
expression alone had a significantly reduced risk of death compared with those with high MMP11 and low P14
ARF
expression. The reduced risk for overall death was pronounced for patients with low and high expression of both genes (HR, 0.2; 95% CI, 0.1-0.5) compared with any other co-expression status of both genes, particularly for patients with surgery only (HR, 0.1; 95% CI, 0.0-0.9). Conclusion: These results suggest that altered expression of MMP11 and P14
ARF
in tumors may individually, or in combination, predict poor prognosis of LSCC, particularly for patients with surgery only. |
---|---|
Bibliography: | Equal contributors. |
ISSN: | 1940-5901 |